Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reductive microbial conversion of anthracycline antibiotics

V P Marshall, E A Reisender, L M Reineke

    Biochemistry
    |September 21, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Characterization of process air emissions in automotive production plants.

    Journal of occupational and environmental hygiene·2015
    Same author

    Correlates of adolescent pessimism: A study of the beck hopelessness scale.

    Journal of youth and adolescence·2013
    Same author

    Gonorrheal Prophylaxis.

    Journal of the National Medical Association·2010
    Same author

    Argon bomb pumping of ruby laser.

    Applied optics·2010
    Same author

    Characterization of mutagenic subfractions of diesel exhaust modified by ceramic particulate traps.

    Environmental science & technology·2009
    Same author

    Low-coherence heterodyne photon correlation spectroscopy.

    Applied optics·2008

    Microaerophilic bacteria like Aeromonas hydrophila can convert anthracycline glycosides into 7-deoxyaglycones. This reductive conversion, dependent on DPNH, is more efficient with A. hydrophila under anaerobic conditions.

    Area of Science:

    • Microbiology
    • Biochemistry
    • Drug Metabolism

    Background:

    • Anthracycline glycosides are a class of compounds with significant biological activity.
    • Understanding their metabolic pathways is crucial for drug development and understanding microbial interactions.

    Purpose of the Study:

    • To investigate the reductive conversion of anthracycline glycosides by specific bacterial strains.
    • To elucidate the mechanism of 7-deoxyaglycone formation and identify the most efficient microbial catalysts.

    Main Methods:

    • Incubation of anthracycline glycosides with microaerophilic cultures of Aeromonas hydrophila, Citrobacter freundii, and Escherichia coli.
    • Utilizing cell-free extracts of A. hydrophila for DPNH-dependent reductive conversion assays.
    • Analyzing reaction products using techniques to detect hydrolysis and reduction intermediates.

    Related Experiment Videos

    Main Results:

    • Reductive conversion of several anthracycline glycosides (steffimycin, nogalamycin, daunomycin, etc.) to 7-deoxyaglycones was observed with all three bacterial strains under microaerophilic conditions.
    • Aeromonas hydrophila demonstrated superior reaction rates and conversion efficiency compared to C. freundii and E. coli.
    • Evidence suggests direct reductive cleavage, not a multi-step hydrolysis-dehydration-reduction process, as no hydrolysis products were detected.

    Conclusions:

    • Microaerophilic bacteria, particularly A. hydrophila, can effectively catalyze the reductive conversion of anthracycline glycosides to 7-deoxyaglycones.
    • The process requires anaerobic conditions and appears to proceed via direct reductive cleavage.
    • These findings highlight a novel microbial transformation pathway for anthracyclines.